Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance
Fei Cao, Yulong Li, Furong Ma, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 506-518
Closed Access | Times Cited: 8

Showing 8 citing articles:

ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation
Furong Ma, Yulong Li, Mao-Hua Cai, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116387-116387
Closed Access | Times Cited: 8
Ferroptosis Inducers Erastin and RSL3 Enhance Adriamycin and Topotecan Sensitivity in ABCB1/ABCG2-Expressing Tumor Cells
L. Perera, Shalyn M. Brown, Brian B. Silver, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 635-635
Open Access
Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/Vcr Cells
Qin Ouyang, Bo Xu, Tao Yu, et al.
(2025)
Closed Access
An updated review on the role of small molecule in mediating protein degradation
Zumei Wu, Yulong Li, Jinyun Dong, et al.
European Journal of Medicinal Chemistry (2025), pp. 117370-117370
Closed Access
Small molecule inhibitors targeting heat shock protein 90: An updated review
Yulong Li, Jinyun Dong, Jiang‐Jiang Qin
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116562-116562
Closed Access | Times Cited: 5
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106007-106007
Open Access | Times Cited: 2
Highly Potent and Intestine Specific P‐Glycoprotein Inhibitor to Enable Oral Delivery of Taxol
Xianjing Zhou, Ping Zhang, Yuyan Yang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 45
Closed Access | Times Cited: 2
Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based library
Tao Yu, Rong Zeng, Yu Guan, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1675-1685
Closed Access | Times Cited: 1
Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer
Jinyun Dong, Yulong Li, Zhiyuan Jin, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 114, pp. 117944-117944
Closed Access | Times Cited: 1
Highly Potent and Intestine Specific P‐Glycoprotein Inhibitor to Enable Oral Delivery of Taxol
Xianjing Zhou, Ping Zhang, Yuyan Yang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 45
Closed Access
Page 1

Scroll to top